Investigational Site Number 840022

Canton, Ohio 44718

0 studies enrolling now · 1 studies all time

What they study most

Prostate Cancer Metastatic

Studies at this site

• Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide — Stopped early